Study reveals target for drug development for chronic jaw pain disorder – EurekAlert (press release)

by admin on August 2, 2013

Study reveals target for drug development for chronic jaw pain disorder
EurekAlert (press release)
DURHAM, N.C. — Temporomandibular joint disorder (TMJD) is the most common form of oral or facial pain, affecting over 10 million Americans. The chronic disorder can cause severe pain often associated with chewing or biting down, and lacks effective 

View full post on chronic pain – Google News

Previous post:

Next post: